Skip to main content
2025 CRT Conference Main banner
Back

CRT 2025

Coronary

Cardiogenic Shock

Panel Discussion | Is It Feasible to Conduct Meaningful Randomized Clinical Trials for Cardiogenic Shock in 2025 and Beyond?

Sunday, March 9, 2025
12:02 PM – 12:20 PM ET

    Panel Moderator(s)

  • Maya Guglin, MD

    Director of Heart Failure/Transplant/MCS
    Indiana University
    Indianapolis, Indiana, United States

    Disclosure information not submitted.

  • Srihari S. Naidu, MD, FSCAI

    Director, Cath Labs and HCM Program
    Westchester Medical Center
    Valhalla, New York, United States

    Disclosure(s): No financial relationships to disclose

  • Alexander G. Truesdell, MD

    Interventional Cardiology
    Virginia Heart / Inova Schar Heart and Vascular Institute
    McLean, Virginia, United States

    Disclosure(s): Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Getinge: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Zoll: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

    • Panel Discussant(s)

  • Carlos L. Alviar, MD, FACC

    Director, Cardiac and Coronary Care Unit, Director ECMO Program
    Bellevue Hospital Center, New York University School of Medicine, New York, United States

    Disclosure information not submitted.

  • Babar Basir, DO

    Directory of Acute Mechanical Circulatory Support
    Henry Ford Hospital
    Detroit, Michigan, United States

    Disclosure(s): Abiomed Inc: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Consultant (Ongoing); Chiesi Inc: Consultant (Ongoing); Zoll/Therox: Consultant (Ongoing)

  • Daniel Burkhoff, MD, PhD

    Director: Heart Failure, Hemodynamics and MCS Research
    Cardiovascular Research Foundation
    New York, New York, United States

    Disclosure information not submitted.

  • Nihar Desai, MD, MPH

    Associate Professor of Medicine, Vice Chief, Cardiovascular Medicine
    Yale School of Medicine
    Shelton, Connecticut, United States

    Disclosure(s): No financial relationships to disclose

  • Timothy D. Henry, MD

    Director, The Carl and Edyth Lindner Center for Research and Education
    The Christ Hospital
    Bellevue, Kentucky, United States

    Disclosure(s): No financial relationships to disclose

  • Mitchell Krucoff, MD, FACC, FAHA, FSCAI

    Professor Medicine/Cardiology
    Duke University Medical Center/Duke Clinical Research Institute
    Durham, North Carolina, United States

    Disclosure information not submitted.

  • JM

    Jacob Eifer Moeller, MD

    Consultant
    Rigshospitalet Copenhagen Denmark

    Disclosure(s): Abiomed: Grant/Research Support (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Novo Nordic Foundation: Grant/Research Support (Ongoing)

  • Pooja Swamy, MD

    Interventional Cardiologist
    Loma Linda University Health , California, United States

    Disclosure information not submitted.

  • Holger Thiele, MD

    Head of department
    Heart Center Leipzig
    Leipzig, Sachsen, Germany

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Srihari S. Naidu, MD, FSCAI: No financial relationships to disclose
Alexander G. Truesdell, MD: Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Getinge: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Zoll: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Babar Basir, DO: Abiomed Inc: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Consultant (Ongoing); Chiesi Inc: Consultant (Ongoing); Zoll/Therox: Consultant (Ongoing)
Nihar Desai, MD, MPH: No financial relationships to disclose
Andrew Farb, MD: No financial relationships to disclose
Timothy D. Henry, MD: No financial relationships to disclose
Jacob Eifer Moeller, MD: Abiomed: Grant/Research Support (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Novo Nordic Foundation: Grant/Research Support (Ongoing)
Holger Thiele, MD: No financial relationships to disclose